These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11374863)

  • 1. Tamoxifen and estrogen effects on TGF-beta formation: role of thrombospondin-1, alphavbeta3, and integrin-associated protein.
    Harpel JG; Schultz-Cherry S; Murphy-Ullrich JE; Rifkin DB
    Biochem Biophys Res Commun; 2001 Jun; 284(1):11-4. PubMed ID: 11374863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
    Koli K; Keski-Oja J
    Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation.
    Doyen V; Rubio M; Braun D; Nakajima T; Abe J; Saito H; Delespesse G; Sarfati M
    J Exp Med; 2003 Oct; 198(8):1277-83. PubMed ID: 14568985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-associated protein and thrombospondin-1 as endothelial mechanosensitive death mediators.
    Freyberg MA; Kaiser D; Graf R; Vischer P; Friedl P
    Biochem Biophys Res Commun; 2000 May; 271(3):584-8. PubMed ID: 10814505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of TGF-beta1 through up-regulation of TSP-1 by retinoic acid in retinal pigment epithelial cells.
    Uchida H; Kuroki M; Shitama T; Hayashi H; Kuroki M
    Curr Eye Res; 2008 Feb; 33(2):199-203. PubMed ID: 18293192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
    Maile LA; Clemmons DR
    Circ Res; 2003 Nov; 93(10):925-31. PubMed ID: 14563713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.
    Brandt S; Kopp A; Grage B; Knabbe C
    Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 differentially regulates release of IL-6 and IL-10 by human monocytic cell line U937.
    Yamauchi Y; Kuroki M; Imakiire T; Abe H; Uchida H; Beppu R; Yamashita Y; Kuroki M; Shirakusa T
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1551-7. PubMed ID: 11820799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.
    Mauel S; Kruse B; Etschmann B; von der Schulenburg AG; Schaerig M; Stövesand K; Wilcken B; Sterner-Kock A
    APMIS; 2007 Jun; 115(6):687-700. PubMed ID: 17550376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts.
    Koli K; Hyytiäinen M; Ryynänen MJ; Keski-Oja J
    Exp Cell Res; 2005 Nov; 310(2):370-82. PubMed ID: 16157329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation.
    Sakamoto Y; Miyazaki A; Tamagawa H; Wang GP; Horiuchi S
    Atherosclerosis; 2005 Nov; 183(1):85-93. PubMed ID: 15907858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro.
    Flügel-Koch C; Ohlmann A; Fuchshofer R; Welge-Lüssen U; Tamm ER
    Exp Eye Res; 2004 Nov; 79(5):649-63. PubMed ID: 15500824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-beta.
    Fang XQ; Fang M; Fan SW; Gu CL
    Chin Med J (Engl); 2009 Jul; 122(14):1631-5. PubMed ID: 19719963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin-1 induces differential response in human corneal and conjunctival epithelial cells lines under in vitro inflammatory and apoptotic conditions.
    Soriano-Romaní L; García-Posadas L; López-García A; Paraoan L; Diebold Y
    Exp Eye Res; 2015 May; 134():1-14. PubMed ID: 25753839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.